Participation of the Arachidonic Acid Cascade Pathway in Macrophage Binding/Uptake of Oxidized Low Density Lipoprotein.
-
- Beppu Masatoshi
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Watanabe Mitsuhiro
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Sunohara Masaru
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Ohishi Kenji
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Mishima Eriko
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Kawachi Hirokazu
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Fujii Motohiro
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
-
- Kikugawa Kiyomi
- School of Pharmacy, Tokyo University of Pharmacy and Life Science
Search this article
Description
Arachidonic acid cascade inhibitors, including phospholipase A2 inhibitors, dexamethasone and quinacrine (mepacrine), cyclooxygenase inhibitors, indomethacin and aspirin, and lipoxygenase inhibitor AA861, prevented foam cell formation and cholesterol accumulation in the incubation of thioglycollate-induced mouse peritoneal macrophages with oxidized low density lipoprotein (LDL) at 37 °C for 24 h. These inhibitors similarly prevented foam cell formation of fibronectin- and Ca ionophore A23187-stimulated macrophages. Binding and/or uptake of DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine)-acetyl LDL by macrophages at 37 °C for 3 h and arachidonic acid release from macrophages at 37 °C for 4 h were inhibited by dexamethasone. Exogenously added phospholipase A2 of bee venom and Crotalus adamanteous venom increased arachidonic acid release during incubation for 2 h, and increased macrophage binding and/or uptake of DiI-acetyl LDL at 37 °C for 3 h, and foam cell formation at 37 °C for 24 h. Protein kinase inhibitors, ML-9 and staurosporine, that inhibited macrophage binding and/or uptake of DiI-acetyl LDL did not inhibit arachidonic acid release, indicating that protein phosphorylation was not involved in the arachidonic acid pathway in the macrophage scavenger receptor activation. Nordihydroguaiaretic acid that inhibited arachidonic acid release prevented binding and/or uptake of DiI-acetyl LDL. The release of arachidonic acid was not enhanced by fibronectin-stimulation, indicating that Ca influx-dependent stimulation of macrophage activity was not through the activation of phospholipase A2. These results indicate that, as well as the fibronectin-stimulated Ca influx pathway and protein phosphorylation pathway, the arachidonic acid pathway participated in the activation of macrophages to bind and take up oxidized LDL.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 25 (6), 710-717, 2002
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204627858432
-
- NII Article ID
- 110003638744
-
- NII Book ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD38XkvV2hu7k%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 6174905
-
- PubMed
- 12081134
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed